Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine for Cocaine Dependence in Opioid-Maintained Users
NCT01802515Phase 2Terminated
- Sponsor
- Yale University
- Start
- Dec 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atomoxetine in cocaine dependence, sponsored by Yale University. Started Dec 2012; status: terminated.
02
Drugs
atomoxetine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT01802515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802515.